2024
Extracellular Matrix Remodeling Alleviates Memory Deficits in Alzheimer's Disease by Enhancing the Astrocytic Autophagy‐Lysosome Pathway
Abstract: Extracellular matrix (ECM) remodeling is strongly linked to Alzheimer's disease (AD) risk; however, the underlying mechanisms are not fully understood. Here, it is found that the injection of chondroitinase ABC (ChABC), mimicking ECM remodeling, into the medial prefrontal cortex (mPFC) reversed short‐term memory loss and reduced amyloid‐beta (Aβ) deposition in 5xFAD mice. ECM remodeling also reactivated astrocytes, reduced the levels of aggrecan in Aβ plaques, and enhanced astrocyte recruitment to surrounding …
Search citation statements
Paper Sections
Select...
20
5
3
0
Citation Types
0
15
0
0
Year Published
Range
2024
2026
Publication Types
Select...
22
4
Relationship
1
25
Authors
Journals
Cited by 25 publications
(15 citation statements)
References 71 publications
0
15
0
0
Smart CitationsHow the paper below cites the one you are viewing
“…Additionally, the resulting disaccharides from CSPG degradation with chABC give rise to a noncytotoxic activated microglial phenotype protective against experimental autoimmune encephalomyelitis, spinal cord injury, and neurotoxicity models 79 – 82 , which could explain reduced Aβ deposition at 5 months. 83 Thus, these contrasting findings are likely due to the effects of acute PNN degradation vs. long-term ablation as explored in this study. Unlike chABC, which broadly degrades CSPGs and alters ECM composition, potentially triggering acute remodeling and microglial clearance, our model isolates ACAN loss without disturbing other matrix components.…”
Section: Discussion
mentioning
confidence: 84%